ARWR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ARWR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Arrowhead Pharmaceuticals's cost of goods sold for the three months ended in Dec. 2023 was $0.0 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Dec. 2023 was $0.0 Mil.
Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Arrowhead Pharmaceuticals's Gross Margin % for the three months ended in Dec. 2023 was 100%.
Cost of Goods Sold is also directly linked to Inventory Turnover.
The historical data trend for Arrowhead Pharmaceuticals's Cost of Goods Sold can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arrowhead Pharmaceuticals Annual Data | |||||||||||||||||||||
Trend | Sep14 | Sep15 | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | |||||||||||
Cost of Goods Sold | Get a 7-Day Free Trial | - | - | - | - | - |
Arrowhead Pharmaceuticals Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cost of Goods Sold | Get a 7-Day Free Trial | - | - | - | - | - |
Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.
Cost of Goods Sold for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arrowhead Pharmaceuticals (NAS:ARWR) Cost of Goods Sold Explanation
Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.
Arrowhead Pharmaceuticals's Gross Margin % for the three months ended in Dec. 2023 is calculated as:
Gross Margin % | = | (Revenue | - | Cost of Goods Sold) | / | Revenue |
= | (3.551 | - | 0) | / | 3.551 | |
= | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.
Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:
Arrowhead Pharmaceuticals's Inventory Turnover for the three months ended in Dec. 2023 is calculated as:
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 0 | / | 0 | |
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.
Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.
Thank you for viewing the detailed overview of Arrowhead Pharmaceuticals's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.
James C Hamilton | other: Senior Vice President | 177 EAST COLORADO BLVD, SUITE 700, PASADENA CA 91105 |
Victoria Vakiener | director | C/O EPIZYME, INC., 400 TECHNOLOGY SQUARE, CAMBRIDGE MA 02139 |
Mauro Ferrari | director | 201 SOUTH LAKE AVENUE, PASADENA CA 91101 |
William D. Waddill | director | C/O CALITHERA BIOSCIENCES, 343 OYSTER POINT BLVD, SUITE 200, SO. SAN FRANCISCO CA 94080 |
Douglas B Given | director | C/O NEORX CORP, 410 WEST HARRISON ST, SEATTLE WA 98119 |
Tracie Oliver | officer: Chief Commercial Officer | 177 E COLORADO BLVD, SUITE 700, PASADENA CA 91105 |
Patrick O'brien | officer: General Counsel | 225 S. LAKE AVENUE SUITE 1050, PASADENA CA 91101 |
Martin Javier San | officer: Chief Medical Officer | 177 E COLORADO BLVD, STE 700, PASADENA CA 91105 |
Kenneth Allen Myszkowski | officer: CFO | ARROWHEAD RESEARCH CORPORATION, 201 SOUTH LAKE AVENUE, SUITE 703, PASADENA CA 91101 |
Christopher Richard Anzalone | director, officer: President and CEO | ARROWHEAD RESEARCH CORPORATION, 201 SOUTH LAKE AVENUE, SUITE 703, PASADENA CA 91101 |
Adeoye Y Olukotun | director | 3621 SOUTH STATE ST, 695 KMS PL, ANN ARBOR MI 48108 |
Backer Marianne De | director | 177 E COLORADO BLVD, SUITE 700, PASADENA CA 91105 |
Michael S Perry | director | C/O BIOTRANSPLANT INC, 196 BOSTON AVE SUITE 2800, MEDFORD MA 02155 |
James Hassard | officer: Chief Commercial Officer | 177 E COLORADO BLVD, STE 700, PASADENA CA 91105 |
Curt Bradshaw | officer: Chief Scientific Officer | 177 E COLORADO BLVD, STE 700, PASADENA CA 91105 |
From GuruFocus
By Business Wire • 07-06-2023
By Business Wire • 09-11-2023
By Business Wire • 11-21-2023
By Business Wire Business Wire • 06-01-2023
By GuruFocus Research • 01-05-2024
By Business Wire • 01-05-2024
By Business Wire • 11-13-2023
By Business Wire • 09-27-2023
By Business Wire • 08-07-2023
By Business Wire • 12-29-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.